REZI vs VRTX · P/E 75, rev $3.89B vs P/E 30, rev $3.33B
Resideo Technologies Inc (REZI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Resideo Technologies Inc (REZI) is a industrial distribution company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported REZI revenue for 2026-07-04 was $3.89B. Net income was $135.0M. REZI currently screens at market cap $3.44B and trailing P/E 74.7.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
REZI currently screens at market cap $3.44B and trailing P/E 74.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the REZI and VRTX stock pages for the full models.
Not investment advice.